Originally, A3B and other APOBEC3s were thought to inhibit viral infection by inducing mutations in the viral genome via their CDA, but catalytically inactive A3B mutants nevertheless retain significant HIV-1 inhibitory activity8. The gene discussed is APOBEC3B; the disease is viral infectious disease.